StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by polo11on Aug 11, 2016 10:45am

130 Views

Post# 25130646

RE:RE:RE:RE:Exact Sciences Completes 54,000 Cologuard Tests

EXAS has a colon cancer diagnostic approved TEST
GEN has a colon cancer diagnostic approved TEST

EXAC is not profitable at 16 000 tests/month - 44m $ loss
GEN will be break even at 3000 test/month

GEN was doing 22000 test /month at peak in 2014 with 1000 physician enrolled
After restructurtion GEN expect to be back at 1000 physician by year end

EXAS market cap is 1.9b
GEN market cap is 12m.

EXAS has only a colon cancer test
GEN has Colon - Prostate -lung and brest

Bullboard Posts

Anaergia expands relationship with PepsiCo